project id: TCGA-LUAD; case submitter id: TCGA-55-7816; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 49; days to birth: -18170; days to death: 468; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1962; age at diagnosis: 18170; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 44.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 47.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.3; longest dimension: 0.3; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-55-7816-01A-11; percent lymphocyte infiltration: 10.0; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 70.0;